NCT02519374View on ClinicalTrials.gov

Fiber Tolerability in Children

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
Signs and Symptoms, Digestive
Interventions
DRUG

Placebo (including Maltodextrin)

DRUG

PROMITOR® (including Maltodextrin)

Investigational product dose 1

DRUG

PROMITOR® (including Maltodextrin)

Investigational product dose 2

DRUG

PROMITOR® (including Maltodextrin)

Investigational product dose 3

Trial Locations (2)

1000

Metabolic Unit, Clinical Development Unit Nestec, Lausanne

44800

Biofortis, Saint-Herblain

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT02519374 - Fiber Tolerability in Children | Biotech Hunter | Biotech Hunter